Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |